Skip to Main Content

Author Details

Erika Ginsburg
National Cancer Institute, National Institutes of Health
1973
50
27
PMIDPaper TitleJournal TitlePublished Year
34273100Building Capacity for Global Cancer Research: Existing Opportunities and Future Directions.J Cancer Educ2021
27449292Beta protein 1 homeoprotein induces cell growth and estrogen-independent tumorigenesis by binding to the estrogen receptor in breast cancer.Oncotarget2016
25624167Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion?Endocr Relat Cancer2015
23292841Outcome evaluation of the National Cancer Institute career development awards program.J Cancer Educ2013
24142695Mechanisms of transient signaling via short and long prolactin receptor isoforms in female and male sensory neurons.J Biol Chem2013
22457812Progesterone receptor activates Msx2 expression by downregulating TNAP/Akp2 and activating the Bmp pathway in EpH4 mouse mammary epithelial cells.PLoS One2012
22952723Effects of age and parity on mammary gland lesions and progenitor cells in the FVB/N-RC mice.PLoS One2012
23048206Characterization of ο7/11, a functional prolactin-binding protein.J Mol Endocrinol2012
22731827Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo.Breast Cancer Res2012
22727333Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer.BMC Cancer2012
21238538Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP.Mol Cell Endocrinol2011
20578247Local regulation of human breast xenograft models.J Cell Physiol2010
21144038Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies.BMC Cancer2010
2111332916 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo.Horm Cancer2010
20492690The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo.BMC Med2010
20484027CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer.Cancer Res2010
19170109Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.J Cell Physiol2009
19906290Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines.Breast Cancer Res2009
19493163Identification of a regulatory loop for the synthesis of neurosteroids: a steroidogenic acute regulatory protein-dependent mechanism involving hypothalamic-pituitary-gonadal axis receptors.J Neurochem2009
18022314Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.Mol Cell Endocrinol2008
18710550Interlobular and intralobular mammary stroma: genotype may not reflect phenotype.BMC Cell Biol2008
17546050Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2.Oncogene2007
15470002Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland.Biol Reprod2005
16103106S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells.Cancer Res2005
15657343Role of human cripto-1 in tumor angiogenesis.J Natl Cancer Inst2005
15300013Msx-1 and Msx-2 in mammary gland development.J Mammary Gland Biol Neoplasia2004
12759342The neuropeptide galanin augments lobuloalveolar development.J Biol Chem2003
11668597Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland.Dev Dyn2001
11018751Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice.J Endocrinol2000
10395299Progesterone stimulates DNA synthesis and lobulo-alveolar development in mammary glands in ovariectomized mice.J Cell Physiol1999
9343305The regulation of mammary prolactin receptor metabolism by a retroviral envelope protein.J Mol Endocrinol1997
9061502Gene expression of gonadotropin-releasing hormone in early pregnant rat and steroid hormone exposed mouse uteri.J Endocrinol Invest1996
7780973Prolactin synthesis and secretion by human breast cancer cells.Cancer Res1995
7503956Characterization of a monoclonal antibody against human prolactin receptors.Int J Cancer1993
1710949Stimulation of growth of human breast cancer cells (T47D) by platelet derived growth factor.Cancer Lett1991
2985666Isolation, characterization, and regulation of the prolactin receptor.J Dairy Sci1985
3876879Epidermal growth factor stimulates the growth of A431 tumors in athymic mice.Cancer Lett1985
6199131A comparison of the pulmonary toxicity and chemotherapeutic activity of bleomycin-BAPP to bleomycin and pepleomycin.Cancer Chemother Pharmacol1984
6740671Selective damage to nonciliated bronchiolar epithelial cells in relation to impairment of pulmonary monooxygenase activities by 1,1-dichloroethylene in mice.Toxicol Appl Pharmacol1984
6838545Lung-selective impairment of cytochrome P-450-dependent monooxygenases and cellular injury by 1,1-dichloroethylene in mice.Biochem Biophys Res Commun1983
6174728Studies on the interaction of bleomycin A2 with rat lung microsomes. I. Characterization of factors which influence bleomycin-mediated DNA chain breakage.J Pharmacol Exp Ther1982
7082349Studies on the in vitro interaction of mitomycin C, nitrofurantoin and paraquat with pulmonary microsomes. Stimulation of reactive oxygen-dependent lipid peroxidation.Biochem Pharmacol1982
7070230Sex differences in the uptake and retention of imipramine and desmethylimipramine in the rat lung.Life Sci1982
7062279Studies on the interaction of bleomycin A2 with rat lung microsomes. II. Involvement of adventitious iron and reactive oxygen in bleomycin-mediated DNA chain breakage.J Pharmacol Exp Ther1982
7151981Bronchiolar epithelial damage and impairment of pulmonary microsomal monooxygenase activity in mice by naphthalene.Exp Mol Pathol1982
6809311Differential effects of anthracycline drugs on rat heart and liver microsomal reduced nicotinamide adenine dinucleotide phosphate-dependent lipid peroxidation.Cancer Res1982
6277041The effects of adriamycin in vitro and in vivo on hepatic microsomal drug-metabolizing enzymes: role of microsomal lipid peroxidation.Toxicol Appl Pharmacol1981
7281188In vitro stimulation by paraquat of reactive oxygen-mediated lipid peroxidation in rat lung microsomes.Toxicol Appl Pharmacol1981
6791646Clara cell damage and inhibition of pulmonary mixed-function oxidase activity by naphthalene.Biochem Biophys Res Commun1981
4365381Growth inhibition and morphological changes caused by lipophilic acids in mammalian cells.Proc Natl Acad Sci U S A1973
  • 1 - 50 of 50

Recommended Authors

University of Cambridge
Career Start Year 2004
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1997
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 1996
Number of shared co-authors 1
University of California Davis Health
Career Start Year 1995
Number of shared co-authors 0
University of California Riverside
Career Start Year 1992
Number of shared co-authors 0
Oncology R&D
Career Start Year 1992
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
School of Medicine of Sao Paulo University
Career Start Year 1991
Number of shared co-authors 0
University of Texas M.D. Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
Radboud University Medical Centre
Career Start Year 1987
Number of shared co-authors 0
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1987
Number of shared co-authors 0
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 1
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Oncology R&D
Career Start Year 1984
Number of shared co-authors 0
University of California
Career Start Year 1984
Number of shared co-authors 0
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 1
University of Oxford
Career Start Year 1981
Number of shared co-authors 0
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
Blokhin N.N. National Medical Research Center of Oncology
Career Start Year 1979
Number of shared co-authors 0
Hollings Cancer Center, Medical University of South Carolina
Career Start Year 1979
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 1
Westmead Institute for Medical Research, University of Sydney
Career Start Year 1978
Number of shared co-authors 1
University of Colorado School of Medicine
Career Start Year 1978
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 0
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1973
Number of shared co-authors 0
Harvard Medical School
Career Start Year 1971
Number of shared co-authors 1
Oncology R&D
Career Start Year 1966
Number of shared co-authors 1
Sao Paulo University
Career Start Year 1964
Number of shared co-authors 0

Collaborators

University of Virginia School of Medicine
Co-authored papers 4
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 2
Center for Cancer Training, National Cancer Institute, National Institutes of Health
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
Center for Global Health, US National Cancer Institute
Co-authored papers 1
Center for Global Health
Co-authored papers 1
National Cancer Institute, USA and Center for Strategic Scientific Initiatives
Co-authored papers 1
Co-authored papers 1
Center for Global Health, National Cancer Institute, National Institutes of Health
Co-authored papers 1
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers 1
Center for Coregulator Research, Baylor College of Medicine
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
The George Washington University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
National Institutes of Health
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1